ADA2 NOW Trademark

Trademark Overview

On Thursday, April 18, 2024, a trademark application was filed for ADA2 NOW with the United States Patent and Trademark Office. The USPTO has given the ADA2 NOW trademark a serial number of 98506745. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 19, 2024. This trademark is owned by DADA2 Foundation. The ADA2 NOW trademark is filed in the Medical Instrument Products category with the following description:

Point-of-care medical diagnostic device for the quantitative determination and monitoring of adenosine deaminase 2

General Information

Serial Number98506745
Word MarkADA2 NOW
Filing DateThursday, April 18, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2024

Trademark Statements

Pseudo MarkADA TWO NOW
NOT AVAILABLE"ADA2"
Goods and ServicesPoint-of-care medical diagnostic device for the quantitative determination and monitoring of adenosine deaminase 2

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 6, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDADA2 Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFranklin, TN 37069

Trademark Events

Event DateEvent Description
Thursday, April 18, 2024NEW APPLICATION ENTERED
Thursday, October 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 31, 2024ASSIGNED TO EXAMINER
Friday, November 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 1, 2024NON-FINAL ACTION WRITTEN
Friday, November 1, 2024NON-FINAL ACTION E-MAILED
Wednesday, November 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 8, 2024FINAL REFUSAL WRITTEN
Friday, November 8, 2024FINAL REFUSAL E-MAILED
Friday, November 8, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 11, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

determination monitoring adenosine deaminase quantitative device care medical diagnostic point